Gene therapy offers a shortcut to bulking up: At the University of Pennsylvania, H. Lee Sweeney is developing a way to turn the liver into a factory that churns out a muscle growth promoter called
myostatin propeptide.
Not exact matches
Following proteolytic processing, the
propeptide remains bound to the C - terminal dimer and maintains it in an inactive, latent complex [6], [19], [20], which represents one of the major forms of
myostatin that circulates in the blood [21], [22].
Myostatin is synthesized as a precursor protein that undergoes proteolytic processing to generate an N - terminal
propeptide and a C - terminal dimer, which is the biologically active species.
In addition to the
propeptide, other binding proteins are capable of regulating
myostatin activity in vitro, including follistatin [19], [21], FLRG [22], and Gasp - 1 [23].